Ono Pharmaceutical
OPHLY5.0281.02% ( -0.052 )
Ono Pharmaceutical (OPHLY)
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo...
- Open
- 4.930
- High
- 5.028
- Low
- 4.883
- Prev. Close
- 5.080
- Volume
- 22.45K
- Turnover
- 111.71K
- Avg Price
- 4.976
- Bid/Ask Ratio
- --
- Amplitude
- 2.85%
- 52wk High
- 5.750
- Volume Ratio
- 0.41
- Turnover Ratio
- 0.00%
News
- Simplywall · Jul 9 at 10:54 AM
Does Ono’s Expanding Oncology Pipeline and Qinlock Filing Reshape The Bull Case For Ono (TSE:4528)?
- Simplywall · Jun 7 at 12:20 AM
Ono Pharmaceutical (TSE:4528) Is Down 7.0% After Gastric Cancer Drug ONO-4578 Advances To Phase 3 – Has The Bull Case Changed?
- MorningStar · Jun 1 at 06:10 PM
Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting
- MorningStar · May 27 at 06:18 PM
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC)
- Simplywall · May 12 at 05:01 PM
Analyst Estimates: Here's What Brokers Think Of Ono Pharmaceutical Co., Ltd. (TSE:4528) After Its Yearly Report
- benzinga_article · Apr 22 at 10:41 AM
Inhibrx Biosciences shares are trading higher after reports suggesting that the company may see takeover interest from potential suitors including Merck and Ono Pharmaceutical.
